IQVIA Holdings (IQV) Revenue — Quarter Ended Dec 31, 2024
Revenue for the quarter rose compared to both the preceding quarter and the same quarter last year. The increase was supported by continued demand for the company's clinical research and healthcare intelligence services.
Key takeaway
Quarter ended Dec 31, 2024 · FY2024 Q4
Revenue for the quarter rose compared to both the preceding quarter and the same quarter last year. The increase was supported by continued demand for the company's clinical research and healthcare intelligence services.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$4B
Revenue reported for this quarter.
Quarter-over-quarter
+1.6%
Change from the immediately preceding quarter.
Year-over-year
+2.3%
Change from the comparable year-ago quarter.
Trailing four quarters
$15.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2024 | $3.7B | +2.3% |
| Jun 30, 2024 | $3.8B | +2.3% |
| Sep 30, 2024 | $3.9B | +4.3% |
| Dec 31, 2024 | $4B | +2.3% |
Revenue performance
Revenue for the period increased from the immediately preceding quarter, reflecting ongoing business momentum.
Quarterly comparison
Compared to the same quarter one year earlier, revenue also improved. The trend data shows sequential growth over the course of the year.
What to watch
Monitor whether the quarterly revenue growth rate remains consistent with the full-year trend.